• Home
  • Media Events
  • HIMS Jolly Grant permitted three seats each for DM Cardiology and DM Critical Care Medicine

HIMS Jolly Grant permitted three seats each for DM Cardiology and DM Critical Care Medicine

Published on: May 17, 2024

HIMS Jolly Grant permitted three seats each for DM Cardiology and DM Critical Care Medicine

MD Anesthesiology also granted 04 additional seats; total PG seats increased from 123 to 127

Super Speciality seats increased from 12 to 18

There is glad tidings for students focused on pursuing PG and Super Speciality courses in medicine in one of the leading institutions in Uttarakhand. The National Medical Commission (NMC) has approved three seats each for DM Cardiology and DM Critical Care Medicine at the Himalayan Institute of Medical Sciences (HIMS) at Swami Rama Himalayan University, Jolly Grant. Additionally, permission has been granted to increase four seats in MD Anesthesiology.

Principal Dr. Ashok Deorari communicated that the NMC team had sought a report related to the facilities available at the college and hospital. Based on the report, NMC has approved three seats each for DM Cardiology and DM Critical Care Medicine in the PG (MD) course. Permission has also been granted to increase four seats in MD Anesthesiology.

Dr. Ashok Deorari informed that students can gain admission to these seats only after NEET-PG centralized counseling.

Prof. Ashok Deorari, Principal of Himalayan Institute of Medical Sciences,shared his pearls of wisdom and past experiences. He emphasised upon the role of exercise, regular walking, avoiding addictions and adopting good hobbies. He concluded by saying ‘that a healthy body only, can have a healthy mind’ that means physicians must keep themselves healthy first, to treat their patients effectively.

The shortage of experts in Critical Care and Super Speciality healthcare will now be addressed
Principal Dr. Ashok Deorari underlined that critical service is essential in any hospital. There is a shortage of specialists in critical and super speciality healthcare across the country. The increase in PG and Super Speciality seats at HIMS might help reduce the shortage of specialist doctors in hospitals after successful completion of respective courses by aspirants.

PG seats in HIMS increased to 127
After approval from the NMC, permission was also granted to increase four seats in MD Anesthesiology at the Himalayan Institute of Medical Sciences. The total PG seats at HIMS have now increased from 123 to 127, and the Super Speciality course seats have increased from 12 to 18. This is bound to benefit medical students.

HIMS Jolly Grant meets stringent standardsPrincipal Dr. Ashok Deorari reported that the Medical Assessment and Rating Board had set stringent standards including department-specific clinical materials, compliance reports, availability of blood components, functional essential equipment, number of units, number of beds in the department, and faculty numbers. HIMS met these stringent standards. Subsequently, the National Medical Commission (NMC) granted approval to increase seats and start new courses.

HIMS Jolly Grant has a prestigious history

Dr. Deorari mentioned that the Himalayan Institute of Medical Sciences, established in 1995 with the aim of providing skilled doctors and quality medical education, has the honor of being the first private medical college in North India. It also includes the state’s largest super-speciality postgraduate teaching hospital with 1200 beds.

   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.